Advanced searches left 3/3

Blood Cancer - Arxiv

Summarized by Plex Scholar
Last Updated: 10 October 2021

* If you want to update the article please login/register

Blood-derived lncRNAs as potential biomarkers for early cancer diagnosis: The Good, the Bad and the Beauty

Cell-free nucleic acids such as circulating long non-coding RNAs have recently been proposed as a new course of possible biomarkers that could enhance cancer diagnosis. The reported connection between distributing lncRNA levels and the presence of tumors has activated a wonderful amount of rate of interest amongst scientists and medical professionals that have been actively exploring their capacities as reputable cancer biomarkers. We report and review the specificity and level of sensitivity problems of blood-based lncRNAs presently thought about as appealing biomarkers for numerous cancers cells such as hepatocellular carcinoma, intestines cancer, gastric cancer and prostate cancer. Based on different released works, we lastly offer suggestions for detectives that seek to explore and compare the levels of circulating lncRNAs in the blood of cancer patients compared to healthy topics by RT-qPCR or Next Generation Sequencing.

Source link: https://arxiv.org/abs/2109.11746v1

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions